The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125404372 12540437 2 F 20160412 20160802 20160708 20160808 EXP US-ROCHE-1748187 ROCHE 66.00 YR M Y 54.90000 KG 20160808 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125404372 12540437 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) U 125085 SOLUTION FOR INFUSION QOW
125404372 12540437 2 SS FLUOROURACIL. FLUOROURACIL 1 Intravenous (not otherwise specified) U 0 QOW
125404372 12540437 3 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous (not otherwise specified) U 0 QOW
125404372 12540437 4 SS FOLINIC ACID LEUCOVORIN 1 Intravenous (not otherwise specified) U 0 QOW
125404372 12540437 5 C ALLOPURINOL. ALLOPURINOL 1 Unknown 0
125404372 12540437 6 C NYSTATIN. NYSTATIN 1 Unknown 0
125404372 12540437 7 C ONDANSETRON ONDANSETRON 1 Unknown 0
125404372 12540437 8 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown 0 40 MG BID
125404372 12540437 9 C PROTONIX (OMEPRAZOLE) 2 Intravenous (not otherwise specified) 0 40 MG BID
125404372 12540437 10 C TRAZODONE TRAZODONE HYDROCHLORIDE 1 Unknown 0
125404372 12540437 11 C CITALOPRAM CITALOPRAM HYDROBROMIDE 1 Unknown 0
125404372 12540437 12 C CITALOPRAM CITALOPRAM HYDROBROMIDE 1 Unknown 0
125404372 12540437 13 C LORAZEPAM. LORAZEPAM 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125404372 12540437 1 Colon cancer
125404372 12540437 2 Colon cancer
125404372 12540437 3 Colon cancer
125404372 12540437 4 Colon cancer
125404372 12540437 8 Vomiting
125404372 12540437 9 Vomiting

Outcome of event

Event ID CASEID OUTC COD
125404372 12540437 OT
125404372 12540437 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125404372 12540437 Anaemia
125404372 12540437 Confusional state
125404372 12540437 Dehydration
125404372 12540437 Haematemesis
125404372 12540437 Hyperbilirubinaemia
125404372 12540437 Hypertension
125404372 12540437 Hypocalcaemia
125404372 12540437 Hypokalaemia
125404372 12540437 Hypomagnesaemia
125404372 12540437 Hyponatraemia
125404372 12540437 Nausea
125404372 12540437 Suicidal ideation
125404372 12540437 Syncope
125404372 12540437 Thrombocytopenia
125404372 12540437 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125404372 12540437 1 20150113 0
125404372 12540437 2 20150113 0
125404372 12540437 3 20150113 0
125404372 12540437 4 20150113 0
125404372 12540437 5 20150721 0
125404372 12540437 6 20151103 0
125404372 12540437 7 20150707 0
125404372 12540437 8 20160620 0
125404372 12540437 10 20151103 0
125404372 12540437 11 20160412 20160417 0
125404372 12540437 12 20160720 0
125404372 12540437 13 20150616 0